We are live on ! Find out more
BLFS icon

BioLife Solutions

66 hedge funds and large institutions have $154M invested in BioLife Solutions in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 24 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

167% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 9

70% more capital invested

Capital invested by funds: $90.5M → $154M (+$63.3M)

22% more funds holding

Funds holding: 5466 (+12)

5.43% more ownership

Funds ownership: 40.68%46.11% (+5.4%)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
66
Holders Change
+12
Holders Change %
+22.22%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
24
Reduced
9
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CC
1
Casdin Capital
New York
$43.4M
SCM
2
Sandler Capital Management
New York
$17.3M
Vanguard Group
3
Vanguard Group
Pennsylvania
$11M +$915K +57,499 +10%
DCM
4
Driehaus Capital Management
Illinois
$9.35M +$1.41M +88,494 +20%
Renaissance Technologies
5
Renaissance Technologies
New York
$5.54M -$2.13M -133,600 -30%
EIM
6
Essex Investment Management
Massachusetts
$5.4M -$103K -6,503 -2%
SSA
7
Schonfeld Strategic Advisors
New York
$4.92M -$978K -61,500 -18%
BlackRock
8
BlackRock
New York
$4.22M +$1.32M +83,151 +54%
Allianz Asset Management
9
Allianz Asset Management
Germany
$3.59M +$3.19M +200,670 New
RIM
10
Ranger Investment Management
Texas
$3.54M +$1.68M +105,805 +115%
CCM
11
Cadence Capital Management
Massachusetts
$3.49M +$54.7K +3,439 +2%
First Eagle Investment Management
12
First Eagle Investment Management
New York
$3.18M
Ameriprise
13
Ameriprise
Minnesota
$3.13M +$1.15M +72,482 +71%
Fidelity Investments
14
Fidelity Investments
Massachusetts
$2.68M +$2.39M +150,000 New
GIM
15
Granahan Investment Management
Massachusetts
$2.26M -$97K -6,097 -5%
GIP
16
Granite Investment Partners
California
$1.84M +$333K +20,947 +25%
Millennium Management
17
Millennium Management
New York
$1.83M +$1.45M +91,233 +806%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$1.79M +$260K +16,361 +20%
Wells Fargo
19
Wells Fargo
California
$1.67M +$60.2K +3,784 +4%
Russell Investments Group
20
Russell Investments Group
United Kingdom
$1.62M +$1.44M +90,454 New
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$1.58M +$303K +19,064 +28%
LCM
22
Laurion Capital Management
New York
$1.52M +$575K +36,136 +74%
DFAM
23
Deep Field Asset Management
California
$1.43M -$96.1K -6,040 -7%
Invesco
24
Invesco
Georgia
$1.39M +$824K +51,781 +200%
CS
25
Candriam SCA
Luxembourg
$1.36M

BLFS Hedge Fund Activity: Q1 2019 in Review

66 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2019, worth a combined $154M — up 70% from $90.5M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new BLFS positions and 7 closed out — a net gain of 12 holders — while 24 added to existing stakes and 9 trimmed.

The largest buyer was Allianz Asset Management, opening a new position worth an estimated $3.19M. The largest seller was Renaissance Technologies, cutting an estimated $2.13M.

  • 66 institutional investors held BioLife Solutions (BLFS) as of Q1 2019, up from 54 in Q4 2018.
  • Funds reported $154M of BioLife Solutions stock for Q1 2019, up 70% quarter-over-quarter.
  • 19 funds opened new BioLife Solutions positions in Q1 2019 and 7 closed out, a net change of +12 holders.
  • The largest BioLife Solutions buyer in Q1 2019 was Allianz Asset Management, an estimated $3.19M added.
  • The largest BioLife Solutions seller in Q1 2019 was Renaissance Technologies, an estimated $2.13M sold.

Based on aggregated 13F filings for Q1 2019.